帕立骨化醇 TQ0200
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 131918-61-1 | ¥10,500.00 | 询底价 |
10 mg | 131918-61-1 | ¥4,910.00 | 询底价 |
25 mg | 131918-61-1 | ¥7,850.00 | 询底价 |
5 mg | 131918-61-1 | ¥3,450.00 | 询底价 |
1 mg | 131918-61-1 | ¥1,370.00 | 询底价 |
100 mg | 131918-61-1 | ¥14,270.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Paricalcitol
描述: Paricalcitol 是一种 vitamin D receptor 激活剂,是一种 vitamin D 类似物,用于研究继发性甲状旁腺功能亢进,该疾病与慢性肾功能衰竭有关。
动物实验: After TAC or sham surgery, a subset of the mice is treated with paricalcitol which activates the VDR, at a final dose of 300 ng/kg/day. Paricalcitol is dissolved in a 95% propylene glycol and 5% ethyl alcohol solution. Mice were intraperitoneally injected with paricalcitol (or vehicle only) three times per week on Monday, Wednesday, and Friday for five consecutive weeks. An established anti-hypertrophic and anti-fibrotic treatment, namely the angiotensin II receptor blocker (ARB) losartan is also included. Previous experiments have shown it is feasible and efficacious to dissolve losartan in the drinking water at a concentration of 30 mg/kg/day; mice are treated for five consecutive weeks. So, in total eight groups are studied. Sham (n=10), TAC (n=10), Sham + losartan (Sham-los, n=10), TAC + losartan (TAC-los, n=10), Sham + paricalcitol (Sham-pari, n=10), TAC + paricalcitol (TAC-pari, n=10), Sham + paricalcitol + losartan (Sham-combi, n=10) and TAC + paricalcitol + losartan (TAC-combi, n=10) [2].
体外活性: Paricalcitol (30 nM; HP + PC) produces a significant reduction in calcification relative to the observed in cells in HP medium. Paricalcitol causes a reduction in the levels of nuclear β-catenin to a level similar to that observed in control cells [1].
体内活性: Paricalcitol (300 ng/kg/day) significantly decreases Tau and prevents LV dysfunction in mice. It reduces mRNA expression of ANP, fibronectin and collagen III in the TAC-pari mice [2].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: H2O : Insoluble
Ethanol : 12 mg/mL (38.8 mM)
DMSO : 95 mg/mL (228.02 mM)
关键字: Vitamin D receptor | Vitamin D | Inhibitor | VD/VDR | Paricalcitol | inhibit
相关库: Drug Repurposing Compound Library | Approved Drug Library | Anti-Cancer Drug Library | Anti-Cancer Clinical Compound Library | Pediatric Drug Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | Metabolism Compound Library | NO PAINS Compound Library | Bioactive Compound Library
帕立骨化醇 TQ0200信息由TargetMol中国为您提供,如您想了解更多关于帕立骨化醇 TQ0200报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途